Lupin Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Obeticholic Acid Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Lupin Receives Approval from U.S. FDA for Obeticholic Acid Tablets.".